CCL17

Rôles

En médecine

Notes et références

1. ↑ ^{a b et c} GRCh38: Ensembl release 89: ENSG00000102970 - Ensembl, May 2017
2. ↑ ^{a b et c} GRCm38: Ensembl release 89: ENSMUSG00000031780 - Ensembl, May 2017
3. ↑ « Publications PubMed pour l'Homme », sur National Center for Biotechnology Information, U.S. National Library of Medicine
4. ↑ « Publications PubMed pour la Souris », sur National Center for Biotechnology Information, U.S. National Library of Medicine
5. ↑ Mizukami Y, Kono K, Kawaguchi Y, Akaike H, Kamimura K, Sugai H, Fujii H. CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer, Int J Cancer, 2008;122:2286–2293
6. ↑ Tsunemi Y, Saeki H, Nakamura K et al. CCL17 transgenic mice show an enhanced Th2-type response to both allergic and non-allergic stimuli, Eur J Immunol, 2006;36:2116–2127
7. ↑ Staples KJ, Hinks TS, Ward JA, Gunn V, Smith C, Djukanović R, Phenotypic characterization of lung macrophages in asthmatic patients: overexpression of CCL17, J Allergy Clin Immunol, 2012;130:1404–12
8. ↑ Riis JL, Johansen C, Vestergaard C, Bech R, Kragballe K, Iversen L, Kinetics and differential expression of the skin-related chemokines CCL27 and CCL17 in psoriasis, atopic dermatitis and allergic contact dermatitis, Exp Dermatol, 2011;20:789–794
9. ↑ Radstake TR, van der Voort R, ten Brummelhuis M et al. Increased expression of CCL18, CCL19, and CCL17 by dendritic cells from patients with rheumatoid arthritis, and regulation by Fc gamma receptors, Ann Rheum Dis 2005;64:359–367
10. ↑ Weber C, Meiler S, Döring Y et al. CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in mice, J Clin Invest, 2011;121:2898–2910